Key result
Admission LVEF <23% predicts ~612% higher risk of late lethal ventricular arrhythmias post-AMI.
Why the study?
Little is known regarding factors that predict the occurrence of lethal ventricular arrhythmias occurring after acute myocardial infarction.
Does LVEF at admission predict lethal ventricular arrhythmias in the late phase after acute myocardial infarction in patients with reduced LVEF?
Cohort (n=136)
No
Does LVEF at admission predict lethal ventricular arrhythmias in the late phase after acute myocardial infarction in patients with reduced LVEF?
In patients with AMI and reduced LVEF, an admission LVEF ≤23% is a strong independent predictor of late-phase lethal ventricular arrhythmias.
Answers are grounded in this paper and cite their sources.
Admission LVEF <23% may flag AMI patients for closer late arrhythmia surveillance; hypothesis-generating and requires prospective validation before guiding care.
AIMS: Little is known regarding factors that predict the occurrence of lethal ventricular arrhythmias (VAs) occurring after acute myocardial infarction (AMI). This observational cohort study aimed to identify factors that predicted lethal VAs during the late phase after AMI in patients with reduced left ventricular ejection fraction (LVEF). METHODS AND RESULTS: Data were collected from our AMI database regarding consecutive patients with an LVEF of ≤40% after AMI (January 2012 to July 2018). The 'late phase' was defined as ≥7 days after AMI onset, and the primary endpoint was defined as lethal VAs in the late phase. The study included 136 patients (82% men; mean age: 66 ± 13 years). The average LVEF at admission was 32.7 ± 8.2%. During a mean follow-up period of 20.7 months, 14 patients (10%) experienced lethal VAs, including ventricular fibrillation (n = 8) and sustained ventricular tachycardia (n = 10). Univariate analyses revealed that lethal VAs were predicted by age and LVEF at admission. Receiver operating characteristic curve analysis indicated that the optimal cut-off value was 23% for using the LVEF at admission to predict the primary endpoint (area under the curve: 0.77, P < 0.0001). Multivariable analysis also demonstrated that LVEF at admission was an independent predictor of the primary endpoint (risk ratio = 7.12, P = 0.001). CONCLUSIONS: Lethal VAs in the late phase are common in patients with AMI, and reduced LVEF and cardiac function at admission play a significant role in the risk stratification for future lethal VAs in this population.
No takes yet. Share an insight, caveat, or question.
Saito et al. (2021) conducted a cohort in Acute myocardial infarction with reduced left ventricular ejection fraction (n=136). Left ventricular ejection fraction (LVEF) <23% at admission vs. LVEF ≥23% at admission was evaluated on Lethal ventricular arrhythmias (ventricular fibrillation and sustained ventricular tachycardia) in the late phase (≥7 days after AMI) (RR 7.12, p=0.001). An admission left ventricular ejection fraction of <23% independently predicted the occurrence of lethal ventricular arrhythmias in the late phase after acute myocardial infarction (RR 7.12).
Synapse has enriched 10 related papers. Consider them for comparative context: